29383

29383
Teva Branded Pharmaceutical Products, R&D Inc. A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma. NCT03052725. 2017 [cited: 2019-05-24]. https://clinicaltrials.gov/ct2/show/NCT03052725
Einstellungen
29383
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 25.01.2021 | 18:44 Uhr